Transfer news live updates: Latest on Giovanni Leoni, Marc Guehi and Jadon Sancho
All of it will filter into our daily live coverage here.
The jewel in the crown is the DealSheet, where each Tuesday morning our team — led by the prolific David Ornstein — will take you inside the market to explain the deals being worked on this window across the Premier League and beyond.
We will bring you analysis you can trust about what is happening and why at Europe's leading clubs, with the latest information we're hearing from our sources across the market.
Settle in with a cup of tea because the article is long but detailed, giving you comprehensive knowledge of all the deals in the works— or you can search for the club and players you want to read about.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Trending tickers: Novo Nordisk, Palo Alto Networks, Walmart, Soho House and Nio
Novo Nordisk ( NVO) Copenhagen-listed shares in pharmaceuticals giant Novo Nordisk ( rose nearly 4% on Monday morning, after the company announced that its blockbuster weight-loss drug Wegovy had been approved in the US to treat a form of liver disease. Novo ( said in an announcement on Friday that the US Food and Drug Administration (FDA) had approved Wegovy for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, in combination with a reduced calorie diet and increased physical activity. Read more: Markets mixed as Zelensky and European leaders head to Washington for war talks The company said that accelerated approval is based on part one of a trial, in which Wegovy, demonstrated a statistically significant and superior improvement in liver fibrosis with no worsening of steatohepatitis, as well as resolution of steatohepatitis with no worsening of liver fibrosis compared to a placebo. The news offers a boost to Novo Nordisk ( which has been facing increasing competition in the weight-loss market, with shares in company currently down nearly 46% year-to-date. Martin Holst Lange, executive vice president, chief scientific officer and head of research and development at Novo ( said: "Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide." Palo Alto Networks (PANW) Shares in Palo Alto Networks (PANW) hovered just above the flatline in pre-market trading on Monday morning, ahead of the US cybersecurity company reporting its fourth quarter earnings later in the day. The company had guided to revenue for the quarter in the range of $2.49bn (£1.83bn) to $2.51bn, which would represent year-over-year growth of between 14% and 15%. Shares in the Palo Alto (PANW) came under pressure following the release of its third quarter earnings in May, as the results failed to impress investors. The cybersecurity company's third quarter revenue came in at $2.3bn, just above expectations, while adjusted earnings per share (EPS) were $0.80. Walmart (WMT) Shares in Walmart (WMT) were also trending on Monday, ahead of the company reporting its second quarter earnings on Thursday. Walmart's results are closely watched by investors as it is the largest retailer in the US, so it is considered to act as a barometer for consumer sentiment. The stock is up nearly 11% year-to-date but edged lower after Walmart (WMT) released a mixed set of first quarter results in May. Walmart (WMT) posted first quarter revenue of $165.5bn, which was up 2.5% from the same period last year, though this missed Wall Street expectations of $166.02bn. Adjusted earnings per share grew 1.7% year over year to $0.61, beating estimates of $0.58. US same-store sales also beat expectations with a 4.5% increase, led by health and wellness, and groceries. Stocks: Create your watchlist and portfolio John David Rainey, chief financial officer of Walmart (WMT), said in the earnings release that the company had decided to hold off on providing a specific range of guidance for operating income growth and earnings per share for the second quarter, given the "dynamic nature of the backdrop". Walmart (WMT) did guide to net sales growth of 3.5% to 4.5% for the quarter, based on the $167.8bn it reported a year ago. AJ Bell's (AJB.L) investment director Russ Mould and head of financial analysis Danni Hewson said that analysts expect a headline figure for net sales of $174bn. "That turns into a consensus analysts' forecasts for [net profit in] the second quarter of $5.8bn, and a headline earnings per share (EPS) figure of $0.72, up from $0.67 a year ago," they said. Soho House (SHCO) Shares in Soho House (SHCO) surged 13% in pre-market trading on Monday, following reports that the members' club was nearing a deal to go private. The Wall Street Journal reported on Sunday that a group of investors led by MCR Hotels was nearing a deal to take Soho House private. Read more: Stocks that are trending today They are reportedly expected to pay around $9 per share for the company's outstanding stock, with the deal valuing the company at $1.8bn. A spokeperson for Soho House (SHCO) had not responded to Yahoo Finance UK's request for comment at the time of writing. Nio ( NIO) Shares in Chinese electric vehicle company Nio ( jumped nearly 7% on Monday, after announcing it expansion into three new markets. Nio ( said in announcement on Monday that it planned to enter Singapore, Uzbekistan and Costa Rica in 2025 and 2026. Chris Chen, head of global business development at Nio ( said: "To accelerate our entry into diverse global markets, Nio is partnering with experienced players who have deep local expertise and extensive distributor networks. "They will help us introduce our high-quality smart electric vehicles to new markets more efficiently." Read more: Bank of England cuts gilt holdings by £32.5bn in second quarter The most popular stocks and funds investors bought in July UK job market continues to weaken as vacancies fall
Yahoo
18 minutes ago
- Yahoo
Watford Women sign Marcie O'Meara from Arsenal and Soraya Walsh from West Ham
Watford Women have announced the signings of Marcie O'Meara from Arsenal and Soraya Walsh from West Ham United. O'Meara, recruited on a dual-registration deal, is a midfielder who has become a key member of the Arsenal Under-21s. More: Paulo Pezzolano caught everybody off guard with QPR selection - and it worked a treat She has been handed the number 16 shirt and was on the bench at Lewes on Sunday as the Golden Girls got their campaign going with a 0-0 draw. Walsh, also a midfielder, made her senior Hammers debut last season. She played at this level with Billericay Town and now heads to Watford, as they aim for promotion to WSL 2.
Yahoo
18 minutes ago
- Yahoo
Bulletin from the extraordinary general meeting of Fingerprint Cards AB (publ) on August 18, 2025
Fingerprint Cards AB (publ) held an Extraordinary General Meeting today on August 18, 2025 in Stockholm. A summary of the resolutions passed by the Meeting is set out below. Reverse share split The Meeting resolved, in accordance with the Board of Directors' proposals, to revoke the resolutions adopted by the Annual General Meeting concerning the reverse share split and to amend the articles of association in order to enable a reverse share split. Furthermore, the Meeting resolved on a reverse share split of the Company's shares where 2,000 existing shares shall be consolidated to one share (reverse share split 1:2,000). After the reverse share split has been completed, the number of shares and votes in the Company, based on the current number of outstanding shares, will decrease from 15,175,375,766 shares (7,875,000 A-shares and 15,167,500,766 B-shares) and 15,246,250,766 votes to 7,587,687 shares (3,937 A-shares and 7,583,750 B-shares) and 7,623,120 votes. Each share will have a quota value of approximately SEK 21.353477 after the reverse share split. The aggregation will be done by rounding down for shareholders with excess shares. The Company intends to use an issuing agent for the sale of B shares (corresponding to the sum of the fractions resulting from the rounding down and division). Allocation of new shares to shareholder- and nominee accounts will be made automatically with rounding down. Euroclear will transfer excess shares (corresponding to the sum of fractions) to the issuing agent engaged by the Company, which will be sold by the issuing agent, who will also be responsible for the preparation of control data. Compensation for fractions will be paid to the shareholders concerned by the issuing agent or Euroclear. The excess shares (fractions of A and B shares) that do not entitle to new shares will be cancelled through the resolution. A separate press release will be published once the Board of Directors has determined the record date for the reverse share split. For further information, please contact: Investor Relations, +46(0)10-172 00 10, investrel@ Press, +46(0)10-172 00 20, press@ About FPC Fingerprint Cards AB (FPC) is a global biometrics leader, offering intelligent edge to cloud biometrics. We envision a secure, seamless world where you are the key to everything. Our solutions – trusted by enterprises, fintechs, and OEMs – power hundreds of millions of products, enabling billions of secure, convenient authentications daily across devices, cards, and digital platforms. From consumer electronics to cybersecurity and enterprise, our cloud-based identity management platforms support multiple biometric modalities, including fingerprints, iris, facial, and more. With improved security and user experience, we are driving the world to passwordless. Discover more at our website and follow us on LinkedIn and X for the latest updates. FPC is listed on Nasdaq Stockholm (FING B). Attachment 250818 - Bulletin from Aug 2025 EGM
